Resources

  • 22 Feb 2013

    Payer Management of Immunoglobulin Agents Intensifies

    ZHI, Zitter Health Insights

    read more
  • 22 Feb 2013

    The Zitter Group Rebrands as Zitter Health Insights

    Mark Zitter, CEO, Zitter Health Insights

    The Zitter Group has rebranded as Zitter Health Insights. The new name more accurately represents our core competence in syndicated market research on payer influence on access for life sciences products. As the managed markets landscape became more complex, we began to offer insights in multi-client subscription formats. “Access Answered” is the tagline corresponding with […]

    read more
  • 19 Feb 2013

    New Tools for New Rules

    Mark Zitter, CEO, Zitter Health Insights

    The game has changed. Payers have long attempted to influence the prescribing and use of pharmaceuticals in ways they believe are best for their members and plan sponsors. Health plans and pharmacy benefit managers naturally see this as part of their mission – providing the best care at the lowest cost – as well as […]

    read more
  • 12 Nov 2012

    Health Plans and PBMs Take Action to Limit Utilization of Co-Pay Offset Programs

    Chris Wheeler, Director, Co-Pay Strategies, Zitter Health Insights

    A disturbing trend is emerging in the co-pay assistance marketplace as marketers managing co-pay offset programs face increasing resistance from payers and pharmacy benefits managers (PBMs).  Payers and PBMs complain that co-pay offset programs raise costs by encouraging the use of branded drugs over generics.  They argue that co-pay programs undermine their ability to manage […]

    read more